126 related articles for article (PubMed ID: 16800732)
1. Human kallikrein 10, a predictive marker for breast cancer.
Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V
Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732
[TBL] [Abstract][Full Text] [Related]
2. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer.
Dhar S; Bhargava R; Yunes M; Li B; Goyal J; Naber SP; Wazer DE; Band V
Clin Cancer Res; 2001 Nov; 7(11):3393-8. PubMed ID: 11705853
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression.
Liu XL; Wazer DE; Watanabe K; Band V
Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP
Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815
[TBL] [Abstract][Full Text] [Related]
5. The human kallikrein 10 promoter contains a functional retinoid response element.
Zeng M; Zhang Y; Bhat I; Wazer DE; Band H; Band V
Biol Chem; 2006 Jun; 387(6):741-7. PubMed ID: 16800735
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
7. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines.
Paliouras M; Diamandis EP
Breast Cancer Res Treat; 2007 Mar; 102(1):7-18. PubMed ID: 16897430
[TBL] [Abstract][Full Text] [Related]
8. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
9. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression.
Li B; Goyal J; Dhar S; Dimri G; Evron E; Sukumar S; Wazer DE; Band V
Cancer Res; 2001 Nov; 61(21):8014-21. PubMed ID: 11691827
[TBL] [Abstract][Full Text] [Related]
10. Human kallikrein 10 ELISA development and validation in breast cancer sera.
Ewan King L; Li X; Cheikh Saad Bouh K; Pedneault M; Chu CW
Clin Biochem; 2007 Sep; 40(13-14):1057-62. PubMed ID: 17585892
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
[TBL] [Abstract][Full Text] [Related]
13. Human tissue kallikrein gene family: applications in cancer.
Obiezu CV; Diamandis EP
Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097
[TBL] [Abstract][Full Text] [Related]
14. Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells.
Mangé A; Desmetz C; Berthes ML; Maudelonde T; Solassol J
Biochem Biophys Res Commun; 2008 Oct; 375(1):107-12. PubMed ID: 18687310
[TBL] [Abstract][Full Text] [Related]
15. The role for NES1 serine protease as a novel tumor suppressor.
Goyal J; Smith KM; Cowan JM; Wazer DE; Lee SW; Band V
Cancer Res; 1998 Nov; 58(21):4782-6. PubMed ID: 9809976
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
17. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
18. Downregulation and CpG island hypermethylation of NES1/hK10 gene in the pathogenesis of human gastric cancer.
Huang W; Zhong J; Wu LY; Yu LF; Tian XL; Zhang YF; Li B
Cancer Lett; 2007 Jun; 251(1):78-85. PubMed ID: 17182177
[TBL] [Abstract][Full Text] [Related]
19. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
20. Kallikrein gene downregulation in breast cancer.
Yousef GM; Yacoub GM; Polymeris ME; Popalis C; Soosaipillai A; Diamandis EP
Br J Cancer; 2004 Jan; 90(1):167-72. PubMed ID: 14710225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]